Global Industrial Microbiology Market - Analysis and Forecast (2017-2025)

The industrial microbiology market is a rapidly growing market as pharmaceuticals and biotechnology as well as food and beverages industry and its other end users are emerging due to increasing customer preference towards use of nutraceuticals, growing innovation and automation, and rising collaboration among pharmaceutical companies. Rising preference of customers towards generic medicines and increase in use of microorganisms for various processes such as development of syrup formulations, empty capsules and genetically modified food products as well as bioremediation process are providing an excellent opportunity for the growth of industrial microbiology market.

The research study comprises of a far-reaching analysis of various aspects of the global industrial microbiology market. The segmentation has been done in terms of product type, application, end users type and regions, in order to gain a holistic view of the entire market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the Global Industrial Microbiology market. These include market drivers and restraints, market share analysis, competitive landscape, and key developments etc. 

The key players operating in this industrial microbiology market comprises of Sartorius AG, Merck KGaA, QIAGEN, bioMérieux SA, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Becton Dickinson and Company, Eppendorf AG, Danaher Corporation, Bruker, and Mettler-Toledo International Inc, among other significant players worldwide.

This research report aims at answering various aspects of the global industrial microbiology market with the help of key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that is going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the Global Industrial Microbiology market and assesses the factors governing the same. 

Industrial microbiology involves utilization of microbes in industrial processes like pharmaceutical drugs development, food pathogens testing, vaccines production, industrial fermentation, wastewater and industrial chemical treatment. Industrial microbiology includes the use of microorganisms to manufacture food items, beverages, drugs, cosmetics, biologics and other industrial products in large quantities. Several factors such as increase in significance of industrial food and safety, growing awareness among researchers about new strains of microorganisms, increase in preference for consumer products such as OTC drugs, food items and packaged water, growing demand of pathogen testing in food products, increasing automation in products, growing research initiatives in different fields of industrial microbiology and rising number of collaborations among companies are driving the growth of industrial microbiology market.

There are certain potential factors providing tremendous opportunities for several companies worldwide to grow, sustain and generate revenue in the field of industrial microbiology. Such factors are growing use of generics and OTC drugs by consumers that is providing an excellent opportunity for pharmaceutical and biotechnology companies to develop cost effective therapies. Increase in usage of microorganisms for syrup formulations, genetically modified food products, empty capsules as well as bioremediation process is also providing promising opportunities for this market to grow in coming years. Emergence of automated products, use of biocides and microbicides for water treatment, environmental monitoring, and rapid sterility testing methods, among others are driving factors for the growth of the industrial microbiology market.

The global industrial microbiology market accounted for $2.3 billion revenue in 2016.  In terms of product type, the industrial microbiology market has been categorized into media, blood & sera, reagents & supplements, rapid detection kits assays, instruments, plastic & glassware and others. The media product types have the largest market share. The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.

The geographical region comprises of North America, Europe, Asia-Pacific, Latin America and Rest of the World (RoW). The North America is growing at a CAGR of 5.3% from 2017 to 2025. However, Latin America comprising of Mexico, Brazil, Colombia and Argentina among others, is growing at the highest CAGR of 7.8%. The reason for holding such strong market share is attributed to the rising emphasis on industrial food and safety and rising demand for consumer products. The application segment of this market comprises of food, environmental & waste management, biopharmaceutical, cosmetic and others. Food acquired the highest market value and is growing at a CAGR of 5.6% and is anticipated to reach $XX million by 2025. However, environmental & waste management is growing at the highest CAGR 7% from 2017 to 2025. The market growth in these regions are driven due to increase in drug development, emergence of rapid microbiology testing methods, beneficial patient and reimbursement policy, rise in demand of automated products as well as growing use of OTC and generic drugs. Furthermore, Asia Pacific region is also evolving at a very faster rate which can be attributed to increasing research and development activities in pharmaceutical, biotechnology, and cosmetic industry, increase in adoption of strict quality control methods for industrial food and safety as well as rise in usage of generics and OTC drugs. The end user segment comprises of biopharmaceuticals, commercial quality assurance, research institution, industrial, regulatory bodies and others. The commercial quality assurance acquired the highest market value and growing at a CAGR of 5.5% from 2017 to 2025. 

Other factors driving the growth of the market are increasing collaboration and strategic partnerships among pharmaceutical and biotechnology companies and use of rapid microbial sterility testing methods for detection of microorganisms and pathogens from various samples of pharmaceuticals, cosmetics, vaccine, foods and biologics. Factors restraining the market growth are strict regulatory and testing requirements of products, samples, reagents and equipment. Increase in demand of advanced technology and its applications in industrial microbiology are also reducing the market growth. Marginal increase in costs of accreditations and certifications for products is also hampering the market growth.

These driving factors as well as opportunities in industrial microbiology market is providing an edge to the key players such as 3M, Merck KGaA, Sartorius AG, bioMérieux SA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc, Becton Dickinson and Company, QIAGEN, Eppendorf AG, and Danaher Corporation, Axon Lab AG, and Bruker Corporation, among others to capture large market share, compete, develop new tests and products in the growing market of industrial microbiology.